Prévention secondaire du sujet âgé suivi en médecine générale : influence du suivi cardiologique sur le contrôle des facteurs de risque et l'utilisation des médicaments de prévention. L'étude ELIAGE-MG

Little information is available as regards risk factor control and use of secondary prevention medications in elderly populations with documented atherosclerotic disease. The ELIAGE-MG survey included 3247 patients with cardiovascular disease seen in ambulatory practice. Overall, both the control of risk factors and the use of secondary prevention medications was suboptimal in these patients. However, those having consulted a cardiologist at any time during the previous year had better control of risk factors (and particularly LDL cholesterol and smoking) and were more often prescribed recommended secondary prevention medications.